Its regulation of key targets such as PTEN and PDCD4 leads to activation of the PI3K/AKT/mTOR signaling pathway, enhancing tumor cell proliferation and disrupting normal differentiation [50,114]. The gene discussed is AKT1; the disease is neoplasm.